Procalcitonin As a Biomarker of Infectious Diseases

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 2013 May 18

PMID 23682219

Citations 48

Authors

Hyuck Lee

Affiliations

Soon will be listed here.

Abstract

Traditional biomarkers, including C-reactive protein, leukocytes, erythrocyte sedimentation rate, and clinical signs and symptoms, are not sufficiently sensitive or specific enough to guide treatment decisions in infectious febrile diseases. Procalcitonin (PCT) is synthesized by a large number of tissues and organs in response to invasion by pathogenic bacteria, fungi, and some parasites. A growing body of evidence supports the use of PCT as a marker to improve the diagnosis of bacterial infections and to guide antibiotic therapy. Clinically, PCT levels may help guide the need for empirical antibiotic therapy, source control for infections, and duration of antibiotic therapy. The aim of this review is to summarize the current evidence for PCT in different infections and clinical settings, and to discuss the reliability of this marker in order to provide physicians with an overview of the potential for PCT to guide antibiotic therapy.

Citing Articles

Correlation Between Systemic Inflammation, Gut Microbiome Dysbiosis and Postoperative Complications After the Modified Whipple Procedure.

Breaza G, Hut F, Cretu O, Abu-Awwad S, Abu-Awwad A, Sima L Biomedicines. 2025; 13(1.

PMID: 39857688 PMC: 11762099. DOI: 10.3390/biomedicines13010104.

Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review.

Bosgana P, Ampazis D, Vlachakos V, Tzouvelekis A, Sampsonas F Diagnostics (Basel). 2025; 15(2).

PMID: 39857029 PMC: 11764001. DOI: 10.3390/diagnostics15020145.

A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform.

Iglesias-Ussel M, OGrady N, Anderson J, Mitsis P, Burke T, Henao R Open Forum Infect Dis. 2025; 12(1):ofae729.

PMID: 39758742 PMC: 11697109. DOI: 10.1093/ofid/ofae729.

Clinical Diagnosis of Acute Noma: Essential Infection Markers and Clinical Presentations.

Gebretsadik H Am J Trop Med Hyg. 2024; 112(3):528-532.

PMID: 39626277 PMC: 11884269. DOI: 10.4269/ajtmh.24-0520.

Implementing antimicrobial stewardship: lessons and perspectives from a university-affiliated tertiary hospital in Korea.

Lee S, Lee R, Cho S, Nho D, Ahn H, Lee D Korean J Intern Med. 2024; 39(3):399-412.

PMID: 38715230 PMC: 11076883. DOI: 10.3904/kjim.2023.504.

References

Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G . Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006; 34(7):1996-2003. DOI: 10.1097/01.CCM.0000226413.54364.36. View

Reinhart K, Bauer M, Riedemann N, Hartog C . New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25(4):609-34. PMC: 3485751. DOI: 10.1128/CMR.00016-12. View

Schuetz P, Albrich W, Mueller B . Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011; 9:107. PMC: 3186747. DOI: 10.1186/1741-7015-9-107. View

Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau G . Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164(3):396-402. DOI: 10.1164/ajrccm.164.3.2009052. View

Linscheid P, Seboek D, Nylen E, Langer I, Schlatter M, Becker K . In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology. 2003; 144(12):5578-84. DOI: 10.1210/en.2003-0854. View

Bouadma L, Luyt C, Tubach F, Cracco C, Alvarez A, Schwebel C . Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010; 375(9713):463-74. DOI: 10.1016/S0140-6736(09)61879-1. View

Tang B, Eslick G, Craig J, McLean A . Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007; 7(3):210-7. DOI: 10.1016/S1473-3099(07)70052-X. View

Riedel S . Procalcitonin and antibiotic therapy: can we improve antimicrobial stewardship in the intensive care setting?. Crit Care Med. 2012; 40(8):2499-500. DOI: 10.1097/CCM.0b013e318256b7da. View

Schuetz P, Christ-Crain M, Muller B . Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections--hope for hype?. Swiss Med Wkly. 2009; 139(23-24):318-26. DOI: 10.4414/smw.2009.12584. View

10.

Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W . Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med. 2000; 28(6):1828-32. DOI: 10.1097/00003246-200006000-00024. View

11.

Bagshaw S, Bellomo R . Early diagnosis of acute kidney injury. Curr Opin Crit Care. 2007; 13(6):638-44. DOI: 10.1097/MCC.0b013e3282f07570. View

12.

Brunkhorst F, Heinz U, Forycki Z . Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998; 24(8):888-9. DOI: 10.1007/s001340050683. View

13.

Kopterides P, Siempos I, Tsangaris I, Tsantes A, Armaganidis A . Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010; 38(11):2229-41. DOI: 10.1097/CCM.0b013e3181f17bf9. View

14.

Jereb M, Muzlovic I, Hojker S, Strle F . Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection. 2001; 29(4):209-12. DOI: 10.1007/s15010-001-1165-z. View

15.

Limper M, de Kruif M, Duits A, Brandjes D, van Gorp E . The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010; 60(6):409-16. DOI: 10.1016/j.jinf.2010.03.016. View

16.

Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J . Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007; 7:10. PMC: 1821031. DOI: 10.1186/1471-2334-7-10. View

17.

Matthaiou D, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G . An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med. 2012; 38(6):940-9. DOI: 10.1007/s00134-012-2563-7. View

18.

Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M . Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009; 34(6):1364-75. DOI: 10.1183/09031936.00053209. View

19.

Christ-Crain M, Muller B . Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J. 2007; 30(3):556-73. DOI: 10.1183/09031936.00166106. View

20.

Pfafflin A, Schleicher E . Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem. 2008; 393(5):1473-80. DOI: 10.1007/s00216-008-2561-3. View